Variant position: 421 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 639 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human LSPPKIHVSARSKLIEPFFN KLFLMRVMDIPYLNLEGPDLQ
Mouse LSPPKMCVSARSKLIEPFFN KLFLMRVMDIPYLNLEGPDLQ
Bovine LSPPKSHVSARSKLIEPFFN KLFLMRVMDIPYLNLEGPDLQ
Xenopus laevis LSPPKDYVSCRSKIVRPFFN KLFLMRIMDIPYLNLEGPDLQ
Zebrafish LTPPKSHISARSKLLEPFYN KLFLMRVIDIPYLNMSGPDLQ
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
1 – 639 Poly(A)-specific ribonuclease PARN
419 – 429
Exome sequencing links mutations in PARN and RTEL1 with familial pulmonary fibrosis and telomere shortening.
Stuart B.D.; Choi J.; Zaidi S.; Xing C.; Holohan B.; Chen R.; Choi M.; Dharwadkar P.; Torres F.; Girod C.E.; Weissler J.; Fitzgerald J.; Kershaw C.; Klesney-Tait J.; Mageto Y.; Shay J.W.; Ji W.; Bilguvar K.; Mane S.; Lifton R.P.; Garcia C.K.;
Nat. Genet. 47:512-517(2015)
Cited for: INVOLVEMENT IN PFBMFT4; VARIANT PFBMFT4 ARG-421;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.